Immunic investor relations
Witryna31 gru 2024 · Results of Operations. The Company reported a net loss of $41.5 million for the year ended December 31, 2024, which compared with a net loss of $52.1 million for the prior year. This resulted in a net loss of $0.98 per share for the year ended December 31, 2024, as compared to a net loss of $1.31 per share for 2024, on both a … Witryna23 lut 2024 · Immunic, Inc. (NASDAQ:NASDAQ:IMUX) Q4 2024 Earnings Conference Call February 23, 2024 8:00 AM ETCompany ParticipantsJessica Breu - Head, IR & CommunicationsDaniel Vitt - CEO, President...
Immunic investor relations
Did you know?
Witryna5 kwi 2024 · Immunic is a clinical-stage biopharmaceutical company with a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and … Witryna26 lut 2024 · /PRNewswire/ -- Immunic, Inc. (Nasdaq: ... Head of Investor Relations and Communications +49 89 2080 477 09 [email protected] US IR Contact Rx …
Witryna25 kwi 2024 · Immunic, Inc. Jessica Breu Head of Investor Relations and Communications +49 89 2080 477 09 [email protected]. US IR Contact Rx … Witryna5 sty 2024 · Investor Relations . We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and ... H.C. Wainwright 5th Annual NASH Investor Conference, October 12, 2024. Tuesday, October 12, 2024. 3:30pm - 4:30pm EDT.
Witryna1 kwi 2024 · SAN DIEGO , March 14, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that the Company will present a quantitative systems pharmacology (QSP) model for predicting the effects of the investigational enzyme replacement therapy pegtibatinase, in classical … Witryna23 sie 2024 · Immunic, Inc. (Nasdaq: IMUX) is a clinical-stage biopharmaceutical company with a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases. ... Head of Investor Relations and Communications. Standort. Größere Karte. Gräfelfing. Lochhamer Schlag 21, 82166 …
Witryna12 kwi 2024 · Immunic, Inc. Jessica Breu Manager IR and Communications +49 89 250 0794 69 [email protected] Or Rx Communications Group Melody Carey +1-917-322-2571 [email protected]
Witryna12 kwi 2024 · For Institutional Investors, Securities Analysts. Phone line：+81-3-3244-3022. Business hours (JST): From Monday to Thursday: 8:45 am to 5:45 pm, Friday: 8:45 am to 4:00 pm (closed on Saturdays, Sundays, national holidays and company holidays) lithophane lampeWitryna29 kwi 2016 · About Immunic. Immunic AG (www.immunic.de) is a start-up biotech company founded in April 2016 and focused on the development of immune modulators to block Th17- and Th1-mediated immune and autoimmune responses. The company’s two development programs include orally available, small molecule inhibitors of … lithophane kitWitrynaSEC Filings. Select the filing type and date range you wish to view from the drop-down menus below. An annual report to security holders. Open An annual report to security holders. in HTML. Open An annual report to security holders. in DOC file. Open An annual report to security holders. in PDF file. lithophane lamp kitWitrynaInvestor Relations. Athenex is a global oncology focused biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer, aiming to develop safer and more efficacious cancer medication. Founded in 2003 and based in Buffalo, New York, our mission is to improve the lives … lithophane lanternWitrynaImmunic is a clinical-stage biopharmaceutical company with a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune … lithophane ledWitryna26 lut 2024 · Immunic expressly disclaims all liability in respect to actions taken or not taken based on any or all the contents of this press release. Contact Information. Immunic, Inc. Jessica Breu Head of Investor Relations and Communications +49 89 2080 477 09 [email protected]. US IR Contact Rx Communications Group … lithophane lamp shade creatorWitryna8 lut 2024 · Mersana Fourth Quarter 2024 Earnings Call. February 28, 2024 at 8:00 AM EST. Listen to webcast. lithophane lamp shade